Please login to the form below
BMSs
This page shows the latest BMSs news and features for those working in and with pharma, biotech and healthcare.
BMS’s Reblozyl meets primary endpoint in myelodysplastic syndromes phase 3 trial
The study showed significant improvements in red blood cell transfusion independence
Latest news
-
FDA approves BMS’s Opdualag for metastatic or unresectable melanoma
The new, first-in-class fixed-dose dual immunotherapy combination treatment is administered as a single intravenous infusion
-
BMS’s oral AML therapy Onureg receives EU approval
Onureg is the oral version of Vidaza, two of the drugs BMS gained as part of its acquisition of Celgene in 2019
-
Celgene says no to Mereo’s cancer drug etigilimab
UK biotech will focus on rare disease drugs
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
- Planting the Seeds for Future Women Leaders in Medicine
- FDA approves SpringWork’s Ogsiveo as first therapy for desmoid tumours
- GSK shares positive phase 3 results for Blenrep combination in multiple myeloma
- Stem cell therapy trial shows promising results for treating progressive MS
- Cancer Research UK calls on government to create ten-year cancer plan
- Risk calculator to prevent heart attacks and strokes in type 2 diabetes patients
No results were found
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
